Goodwin
Dylan Miller
- Deals
- 2
- Latest
- Aug 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 2 deals
Often works with
- Laura Gulick 1 deal together
- Sarah Solomon 1 deal together
- Kimberley Maruncic 1 deal together
- Mitch Bloom 1 deal together
- Rob Dzialo 1 deal together
- Adam Dilluvio 1 deal together
- Tim Ayotte 1 deal together
- Ben Colao 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Aug 2026 | Merida Biosciences | – | Eli Lilly and Company | Acquisition | Legal adviser to Merida Biosciences (target) | Announced | 2,875.0 | Biotech+1 | Eli Lilly and Company acquisition of Merida Biosciences |
| May 2026 | Perfuse Therapeutics | – | Bayer | Acquisition | Legal adviser to Perfuse Therapeutics (target) | Announced | 300.0 | Biotech+2 | Bayer acquisition of Perfuse Therapeutics |
Deals where Dylan Miller is named on the firm's deal team, by the firm or the press.